| 2003 |
Targeted gene disruption of PfRh2a in P. falciparum showed that unlike PfRh2b, PfRh2a does not mediate the novel sialic acid-independent, trypsin-resistant, chymotrypsin-sensitive invasion pathway, and phenotypic variation (variant expression) of the PfRh protein family allows exploitation of different erythrocyte surface receptors. |
Targeted gene disruption (knockout) with erythrocyte invasion assays using enzyme-treated RBCs |
The EMBO journal |
High |
12606570
|
| 2001 |
RH2a (PF3D7_1335400) encodes a >300 kDa protein expressed in late schizonts and localized to the apical end of the merozoite; no binding to mature RBCs or reticulocyte-enriched cell preparations was detected in this study, and antibodies to the protein can inhibit merozoite invasion of RBCs. |
Protein expression analysis, immunofluorescence localization, erythrocyte binding assay, invasion inhibition assay with antibodies |
Infection and immunity |
Medium |
11160005
|
| 2002 |
RH2a protein is expressed in late schizonts and merozoites and is located in apical organelles and on the apical surface; expression of RH2a is variably transcribed and translated across parasite lines (absent in FCB1), indicating phenotypic variation at the protein level. |
Western blot, immunofluorescence, RT-PCR across multiple parasite lines |
Infection and immunity |
Medium |
12228308
|
| 2006 |
PfROM4 (a P. falciparum rhomboid intramembrane protease) cleaves RH2a in a heterologous processing assay, with cleavage dependent on the RH2a transmembrane domain; PfROM1 did not cleave RH2a efficiently in this assay. |
Heterologous rhomboid cleavage assay with substrate transmembrane domain swap experiments |
PLoS pathogens |
Medium |
17040128
|
| 2009 |
Targeted gene disruption of PfRh2a and PfRh2b separately in W2mef parasites showed that both PfRh2b and PfRh2a contribute to efficient sialic acid-independent erythrocyte invasion, and there is strong selective pressure for reconstitution of PfRh2b expression at the expense of PfRh2a expression. |
Targeted gene disruption (knockout) of PfRh2a and PfRh2b individually with invasion assays using sialic acid-depleted erythrocytes |
Molecular microbiology |
High |
19400777
|
| 2010 |
The differential ability of PfRh2a vs. PfRh2b to specify alternative erythrocyte invasion pathways is conferred by their divergent cytoplasmic domains, not by the ectodomain or transmembrane regions, as shown using viable PfRh2a/2b chimeric parasites. |
Generation of chimeric parasites (domain-swap constructs of PfRh2a and PfRh2b) with invasion pathway assays |
Molecular microbiology |
High |
20487292
|
| 2010 |
Loss of function of EBA-181 ablates the ability of PfRh2a/b antibodies to inhibit merozoite invasion, providing evidence that PfRh and EBL proteins functionally interact and work cooperatively during merozoite invasion. |
Single and double gene knockouts of eba genes combined with antibody invasion inhibition assays (growth inhibition assay) |
Infection and immunity |
Medium |
21149582
|
| 2011 |
Native PfRH2a/2b is proteolytically processed near the N-terminus yielding a 220 kDa fragment (sialic acid-independent, trypsin-resistant, chymotrypsin-sensitive erythrocyte binding) and an 80 kDa fragment (sialic acid-dependent, trypsin-resistant, chymotrypsin-sensitive erythrocyte binding); the erythrocyte binding domain was mapped to a conserved 40 kDa N-terminal region common to both PfRH2a and PfRH2b, and recombinant protein of this domain blocks sialic acid-independent invasion. |
Western blot of native protein processing, erythrocyte binding assays with enzyme-treated RBCs, recombinant protein binding, invasion inhibition with antibodies |
PloS one |
Medium |
21386888
|
| 2011 |
PfRh2a undergoes proteolytic cleavage events in the transmembrane region during invasion consistent with PfROM4 activity, releasing the ectodomain; PfRh2a and PfRh2b bind red blood cells and the erythrocyte-binding domain was defined to a 15 kDa N-terminal region of each protein; antibodies to this region block merozoite invasion. |
Proteolytic processing analysis (western blot), erythrocyte binding assay, antibody invasion inhibition assay |
PLoS pathogens |
Medium |
21698217
|
| 2011 |
Using monoclonal antibodies against a unique region of PfRH2a, PfRH2a was shown to translocate from the rhoptry neck to the moving junction during merozoite invasion, independent of the invasion pathway used, suggesting a function beyond receptor binding; PfRH2a is processed both in the schizont and during invasion, producing fragments with different erythrocyte binding properties. |
Live and fixed immunofluorescence with anti-PfRH2a monoclonal antibodies, erythrocyte binding assays with processed fragments |
Infection and immunity |
Medium |
21628513
|
| 2012 |
Aldolase does NOT bind the cytoplasmic tail of RH2a (only RH2b binds aldolase among the two paralogs), indicating RH2a lacks the aromatic amino acid context required for connection to the actin-myosin motor via aldolase; this is consistent with the functional distinction that RH2b but not RH2a is required for erythrocyte invasion. |
Peptide binding assay, surface plasmon resonance (SPR), X-ray crystal structure of aldolase with RH2b cytoplasmic peptide |
mBio |
High |
22991428
|
| 2013 |
RH2a (as a member of the reticulocyte binding-like family) binds heparin, localizing to the apical tip of the merozoite surface; heparin affinity chromatography followed by immunoblot confirmed heparin binding, suggesting heparin masks the apical surface and blocks erythrocyte interaction. |
Heparin affinity chromatography, immunoblot with ligand-specific antibodies, immunofluorescence localization |
Scientific reports |
Low |
24212193
|
| 2018 |
Forward genetic linkage analysis of experimental genetic crosses identified the PfRh2a/PfRh2b locus as the single major determinant of phenotypic variation in two erythrocyte invasion pathways; CRISPR-Cas9 editing confirmed that variation in PfRh2a and PfRh2b expression specifies alternative invasion pathway use. |
Forward genetic screen, whole genome sequencing linkage analysis of genetic cross progeny, CRISPR-Cas9 gene editing, invasion pathway phenotyping |
PLoS pathogens |
High |
30496294
|
| 2025 |
Disruption of pfrh2a in P. falciparum had a less prominent effect on susceptibility to human inhibitory antibodies compared to loss of PfRH1 or PfRH2b, suggesting PfRH2a is a minor target of acquired growth-inhibitory antibodies and plays a lesser role in immune evasion through phenotypic variation relative to PfRH1 and PfRH2b. |
Gene disruption (pfrh2a knockout) parasites challenged with human immune sera in invasion inhibition assays |
Frontiers in immunology |
Medium |
40201183
|